Earlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. So what exactly did the trial find? And what sort of impact ...

Moderna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune response in late-stage study results than two comparable vaccines on the market. The company's ...

Moderna’s combined mRNA-based vaccine for COVID-19 and seasonal influenza ... compared to current flu vaccines, matching GSK’s Fluarix Quadrivalent in adults aged 50 to 64 and outperforming ...